Evidence map›Paper›PMID 24852173›Full record

ArticlePloS one2014

Impact of light/dark cycle patterns on oxidative stress in an adriamycin-induced nephropathy model in rats.

Begoña M Escribano, Antonia Díaz-Moreno, Antonia Moreno, Inmaculada Tasset, Isaac Túnez

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Impact of constant light exposure during pregnancy on skin of neonatal New Zealand rabbits: structural and ultrastructural study.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Article
  5. Article
  6. The pivotal role of melatonin in ameliorating chronic kidney disease by suppression of the renin-angiotensin system in the kidney.Hypertension research : official journal of the Japanese Society of Hypertension · 2019
    Review
  7. Article
  8. Article
  9. Melatonin Prevents Mitochondrial Damage Induced by Doxorubicin in Mouse Fibroblasts Through Ampk-Ppar Gamma-Dependent Mechanisms.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  10. Protecting the melatonin rhythm through circadian healthy light exposure.International journal of molecular sciences · 2014
    Review
4 · The record

Corrections and comments

  • Erratum issued
    Moreno, Antonia [corrected to Díaz-Moreno, Antonia]
5 · Who and what money

Authors and funding

5 authors.

Begoña M EscribanoDepartment of Cell Biology, Physiology and Immunology, Faculty of Veterinary Medicine, Córdoba University, Córdoba, Spain.
Antonia Díaz-Moreno
Antonia MorenoDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, Maimónides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba University, Córdoba, Spain.
Inmaculada TassetDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, Maimónides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba University, Córdoba, Spain.
Isaac TúnezDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, Maimónides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba University, Córdoba, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The principal goal of this study was to determine the effect of the photoperiod on oxidative damage biomarkers in rats submitted to different light/darkness patterns, in a hyperlipidemic nephropathy model (induced by adriamycin), as well as its possible relationship with melatonin and leptin secretion rhythms. To test this hypothesis, six different groups were used (N = 6 rats per group): control (12 h/12h light:dark); exposure to permanent illumination (24 h light); exposure to darkness (22 h dark); injected with adriamycin, 12h/12h light:dark; injected with adriamycin + exposure to permanent illumination and injected with adriamycin + exposure to darkness (22 h dark). The different photoperiods were begun two weeks prior to medication and were maintained up to the day of the animal's sacrifice, ten days after medication. The following parameters were analysed: i) weight evolution; ii) in plasma: urea, creatinine, uric acid, total proteins, albumen, lactate dehydrogenase, creatinine-quinase, aspartate aminotransferase, alanine aminotransferase and total cholesterol; iii) in urine: urea, creatinine, total proteins and microalbumen; iv) biomarkers of oxidative damage in kidneys, heart, liver and brain: lipoperoxides, total glutathione, reduced glutathione, catalase, glutathione peroxidase, glutathione reductase and glutathione transferase; v) melatonin (pineal gland tissue and plasma) and leptin (plasma). From the results obtained it was concluded that the administration of adriamycin generated oxidative stress in renal, cerebral, hepatic and cardiac tissue. Additionally, in the healthy animal, but of a lesser relevance in the adriamycin animal, permanent light worsened the oxidative stress, whereas darkness improved it. This could be related to the circadian rhythm of the inverse release shown by melatonin and leptin, accentuating the release of melatonin in the darkness phase and that of leptin in the light phase. The correlation between melatonin and leptin in the healthy animal seemed to confirm the relationship between both variables and their influence on oxidative damage biomarkers.

Indexed as

Antibiotics, AntineoplasticDoxorubicinOxidative StressPhotoperiodAnimalsDisease Models, AnimalHyperlipidemiasKidney DiseasesLeptinMaleMelatoninNephronsRats, WistarAntibiotics, AntineoplasticDoxorubicinLeptinMelatonin

Identifiers

PMID24852173
PMCPMC4031229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.